Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Benzyl isocyanate | HCID 76639 | — |
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | HCID 54669705 | HCID 54669705 | — |
| Reactant | HCID 131732457 | HCID 131732457 | — |
| Catalyst | Palladium | HCID 23938 | — |
| Solvent | Acetic Acid | HCID 176 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Solvent | Trifluoroacetic acid methylene chloride | HCID 21863450 | — |
| Solvent | Acetonitrile methanol water | HCID 21864137 | — |
| Product | HCID 54669708 | HCID 54669708 | — |
Reaction Steps
The title compound was prepared from (S)-4′-((5-((1-(1-((benzyloxy)carbonyl)piperidin-4-yl)ethyl)carbamoyl)-2,3-dimethyl-1H-indol-1-yl)methyl)-[1,1′-biphenyl]-2-carboxylic-acid (0.175 g, 0.250 mmol) following palladium catalyzed hydrogenation (18 mg, 10% Pd/c) in AcOH (5 mL) and subsequent coupling of the resulting piperidine ((S)-tert-butyl-4′-((2,3-dimethyl-5-((1-(piperidin-4-yl)ethyl)carbamoyl)-1H-indol-1-yl)methyl)-[1,1′-biphenyl]-2-carboxylate) with benzyl isocyanate (6.8 mg, 0.049 mmol) in dicholoromethane (DCM) (1 mL)/di-isopropylethylamine (9.2 μL, 0.053 mmol) and then removal of t-butyl ester in TFA/DCM (1:1, 2 mL). Completion at each synthetic step was monitored by analytical HPLC and the title compound was isolated by reverse phase prep-HPLC (MeOH/Acetonitrile/water) ESI-MS (m/z): 642 [M+1]+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08957093B2 |
|---|
| Source dataset | uspto-grants-2015_02 |
|---|
| ORD ID | ord-4ca940fb529e410b8da889989c66bb0f |
|---|
| Source note | uspto-grants-2015_02 |
|---|